Care
uMed’s registry platform will work alongside WellSky’s network of home-based care organizations to let patients participate in national clinical trials from home.
The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.
The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.
HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
Genentech will leverage Medra's Physical AI, Scientific AI and robotics into its lab systems to accelerate drug discovery.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
Screening rates in northern Queensland lag behind the statewide average.
The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.
The report shows that enterprise AI adoption has surged, with healthcare among the fastest‑growing sectors at 8x year‑over‑year adoption.